Positron emission tomography imaging in nonmalignant thoracic disorders.
about
Assessment of cardiac sarcoidosis with advanced imaging modalitiesSarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report.Nuclear imaging: a powerful novel approach for tuberculosis.Biomechanics of the cardiovascular system: the aorta as an illustratory exampleAssessing Cutaneous Psoriasis Activity Using FDG-PET: Nonattenuation Corrected Versus Attenuation Corrected PET Images.¹⁸F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports.False positive and false negative FDG-PET scans in various thoracic diseases.Gastrointestinal manifestations of chronic granulomatous disease.Sarcoidosis mimicking lymphoma on FDG-PET imagingRadiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy RegimensNoninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects.Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?A rare case of primary muscular non-Hodgkin's lymphoma and a review of how imaging can assist in its diagnosis.Radiological review of pleural tumors.Sarcoidosis and multiple myeloma: Concurrent presentation of an unusual association.Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis.Multiple Bony Metastatic Lesions and Evaluation of Primary: Case Records of a Cancer Research Centre.Unexpected Benefit of the Positron Emission Tomography/Computed Tomography Using 18F-Fluorodeoxyglucose: Report of a Case.Positron emission tomography-computed tomography and 4-hydroxynonenal-histidine immunohistochemistry reveal differential onset of lipid peroxidation in primary lung cancer and in pulmonary metastasis of remote malignancies.Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease.Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.Current clinical use of 18FDG-PET/CT in patients with thoracic and systemic sarcoidosis.Feasibility of assessing [(18)F]FDG lung metabolism with late dynamic PET imaging.Evaluating the possible role of 68Ga-citrate PET/CT in the characterization of indeterminate lung lesions.Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity.An amazing cause of false PET positivity: Diagnosed after a lung cancer surgery.The Use of PET Imaging for Prognostic Integrin α2β1 Phenotyping to Detect Non-Small Cell Lung Cancer and Monitor Drug Resistance Responses.Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer.FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.18 F-FDG uptake in focal organising pneumonia mimicking bronchial carcinoma.Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer.
P2860
Q27024252-13E73420-9340-45E0-B240-5F07993BB499Q33879711-4D96E38B-2A6E-45CB-99E5-D3BF873B5CEEQ34315731-3DE008FE-B103-40FB-9150-8F29BA279E90Q35828277-A082345A-155C-44D1-826B-D0B3360E6674Q36108233-EEA688EB-F980-4F07-9B77-2B79B880D317Q36369664-8E873A79-C07A-4484-B2F5-1C02403569B1Q36426674-1BCECF2A-455D-4B9F-B92B-FA02908BF341Q36592663-72FE93BB-E913-4A01-AB7B-CF80DDCC4B56Q36990276-4C6D7910-A0E0-4172-B30B-7F0AFA563FD8Q37124117-FF1291E3-BA03-4DE7-89C7-FBB707509776Q37409860-D9672738-4001-4440-B738-77E3E6E64BD5Q37586857-828B6861-F8A7-4BBA-BA0F-1F11226A2FC4Q37821378-EC9BA54B-FA15-4523-8316-60E36D4D19CDQ37874166-12F3DBEB-DB66-4F93-B2C7-8D2B96436967Q38077707-63500062-8EDA-4E33-8163-C2270BDC5505Q38143558-51A952E9-4B6E-401D-8C66-76B7D53144EFQ38194122-0435AE44-E62F-46E9-8EF4-D8D95A8174CDQ38341557-BF42C877-074E-4300-AF15-97B9B2F4FC2BQ38602609-55D740F3-00F6-42D0-8790-FA3F2B52AE9FQ40998754-8629294F-795B-4348-B60E-DD7C424E3843Q41643952-29917F8E-CED6-4B34-95EA-4112049B1665Q41876055-ADC8B321-9ABE-4150-9DAB-3560306AB884Q43700008-0FBAFF37-5873-4AF7-830A-98B8B7665D1DQ44652565-429DFD78-5B28-42C3-90FC-4D5C912C25B6Q45327512-47570A7A-E75D-420E-8F5B-48251CE2B30DQ45937107-5F433F9E-5F93-4EDD-A255-300BD2A4778AQ46153146-2425E778-603B-47CE-83A5-2A54430B3D04Q46837736-16EC571C-E658-47F7-A678-3A920AAE3DA8Q48218529-5E4C7928-E4F0-42F1-9D9E-2616E58BC78AQ49165125-1E9344FF-B1D4-45E3-AAAC-37378B2D10DAQ49298111-C1EEB989-1BFD-42D4-B451-CB2F4D287C2DQ51617036-8E6689BD-6965-420B-B63B-0E7F9B0BF999Q51738060-FA9CA1EA-FEA4-45EC-A201-08041CA640AEQ52624089-A7521C20-A6FF-418F-929C-3DCAE44D4F62
P2860
Positron emission tomography imaging in nonmalignant thoracic disorders.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Positron emission tomography imaging in nonmalignant thoracic disorders.
@en
type
label
Positron emission tomography imaging in nonmalignant thoracic disorders.
@en
prefLabel
Positron emission tomography imaging in nonmalignant thoracic disorders.
@en
P2093
P356
P1476
Positron emission tomography imaging in nonmalignant thoracic disorders.
@en
P2093
Abass Alavi
Hongming Zhuang
Jean-Louis Alberini
Lars-Eric Adam
Marc Hickeson
Naresh Gupta
Peeyush Bhargava
P304
P356
10.1053/SNUC.2002.127291
P577
2002-10-01T00:00:00Z